Stress urinary incontinence treatment: Focus should be on identifying best candidates for surgical success in the first place

Johnston, Shawna

doi:10.5489/cuaj.4801

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several management options have been reported to treat this condition, including behavioral therapy, supportive device, pharmacological intervention, and surgical treatment. [ 15 – 18 ] Behavioral therapies mainly consist of healthy bladder habits and training techniques. [ 19 ] It helps patients to change their lifestyle, and to teach them to control and enhance continence ability.…”

Section: Introductionmentioning

confidence: 99%

A retrospective study of neuromuscular electrical stimulation for treating women with post-stroke incontinence

Shen

Liu

2018

Medicine

View full text Add to dashboard Cite

This retrospective study evaluated the effect of using neuromuscular electrical stimulation (NMES) for the treatment of post-stroke urinary incontinence (PSUI) among female population in China.A total of 163 eligible patients with PSUI were included in this study. Of these, 103 patients were assigned to a treatment group, and 60 subjects were assigned to a control group. All patients in both groups received bladder training. In addition, patients in the treatment group also received NMES. All patients were treated for a total of 8 weeks. The outcome measurements included the amount of urine leakage, urinary symptoms and quality of life. The urinary symptoms were measured by the Bristol Female Urinary Symptoms Questionnaire (BFUSQ) score, and the quality of life was assessed by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score. In addition, adverse events were also documented in this study.After 4-week treatment, patients who received NMES did not exert better outcomes in the amount of urine leakage, urinary symptoms, measured by BFUSQ scale, and the quality of life, assessed by ICIQ-SF scale. However, after 8-week treatment, patients in the treatment group showed greater effect in reducing the amount of urine leakage (P < .01), enhancing urinary symptoms, as measured by BFUSQ scale (P < .01), and improving the quality of life, as assessed by ICIQ-SF scale (P < .01), compared with patients in the control group. In addition, no adverse event was recorded during the period of 8-week treatment in this study.The results of this study indicated that NMES may benefit for patients with PSUI after 8-week treatment. Future studies should focus on warranting the results of this study.

show abstract

Section: Introductionmentioning

confidence: 99%